Last reviewed: June 2, 2026 Last updated: June 2, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al
The lessons learned about scale-up complexity, supply variability, and talent management will influence how the industry tackles other therapeutic waves in the future
According to ProHealth's published company information, all products are manufactured in the United States in facilities subject to FDA dietary supplement current Good Manufacturing Practice (cGMP) requirements under 21 CFR Part 111
There are also classes of GSTs that utilize glutathione as a cofactor rather than a substrate